Tostrex (Testosterone)

Quick links to important sections

Tostrex (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tostrex (Testosterone)

Quick Facts

Property Description
Active ingredient Testosterone (INN)
Form Transdermal gel (in a metered-dose pump)
Pharmacological class Androgen and anabolic steroid
Common use Hormone replacement therapy (for male hypogonadism)
Origin Exogenous (synthetic steroid hormone)

What Type of Medicine is Tostrex (Testosterone)?

Tostrex is a specialized prescription-only medicine (POM) that functions as a form of hormone replacement therapy (HRT) intended for adult men. It belongs to the pharmacological class of androgens and anabolic steroids, which are types of sex hormones. Tostrex is specifically utilized to treat conditions associated with established Testosterone deficiency, known as male hypogonadism.

The primary therapeutic role is to correct this hormonal deficit by providing an exogenous hormone to substitute for the body's naturally produced endogenous hormone. This medication is a single-ingredient product, confirming its use for dedicated Testosterone monotherapy.

Testosterone: Composition and Origin

The active ingredient is Testosterone (INN), a compound that is chemically defined as an essential steroid hormone. The Testosterone delivered by this product is a synthetic equivalent of the natural androgen, which allows it to exert its characteristic androgenic effects and anabolic effects in the body. Unlike oral Testosterone preparations, this product is designed for a topical route of administration, supporting a more consistent absorption profile.

The Transdermal Gel Formulation and General Purpose

Tostrex is supplied as a clear transdermal gel—a convenient topical formulation dispensed from a metered-dose pump for precise cutaneous application. The gel utilizes a hydroalcoholic base, containing excipients like ethanol and propylene glycol, which serve to enhance the penetration of the Testosterone through the skin barrier. The general purpose of this treatment method is Hormone Restoration, aiming to maintain stable systemic levels of Testosterone to help mitigate the issues resulting from hormonal deficiency.

Regulatory References

  1. Testosterone Gel 1.62% Labeling (DailyMed)
  2. Tostrex Public Assessment Report (National EU Register)

What side effects are possible with Tostrex (Testosterone)?

Possible Side Effects and Safety Information

Regulatory documents classify possible adverse reactions for transdermal testosterone gel based on the body system affected and their reported frequency in clinical studies. Safety information is organized to communicate both common, expected effects and rare, serious systemic risks.

Frequency-Classified Adverse Reactions

Adverse reactions classified as Common (affecting 1 to 10 users in 100) often involve the application site and changes in blood composition. These include application site reactions (such as erythema or pruritus), acne, headache, and an increase in hematocrit and red blood cell count. Effects on the prostate, specifically an increase in prostate-specific antigen (PSA), are also commonly reported.

Uncommon effects (affecting 1 to 10 users in 1,000) may include gynaecomastia (breast enlargement), depressed mood, or benign prostatic hypertrophy (BPH).

Serious Adverse Reactions and Safety Constraints

The official safety profile highlights several serious risks and constraints. Treatment is contraindicated in men with known or suspected prostate carcinoma or male breast carcinoma, due to the potential for androgens to stimulate tumor growth.

Serious systemic adverse reactions documented in regulatory sources include the potential for Polycythemia (excessive increase in red blood cell mass), which necessitates dose adjustment or discontinuation. Venous Thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is also a documented risk. Caution is required in patients with pre-existing cardiac, renal, or hepatic impairment, as fluid retention (edema) may worsen these conditions.

Certain effects, such as application site reactions and fluid retention, may be more pronounced at the start of treatment. Long-term administration requires mandatory, periodic monitoring of parameters including hematocrit, hemoglobin, and PSA.

Overdose and Emergency Response

Overdose and When to Seek Help: Tostrex (Testosterone)

Official regulatory information indicates that acute, single-dose overdose with Tostrex is unlikely. Overdose presentations are typically characterized by an exaggeration of the known pharmacological effects associated with chronic over-exposure to testosterone, resulting in serum concentrations persistently above the normal male range. There is no specific antidote listed for testosterone overdosage.

Key Overdose Concerns

Concern Manifestations Required Action
Chronic Over-exposure Signs of excessive androgen effects (e.g., changes in libido, aggression), increased risk of cardiovascular and thromboembolic events. Discontinue the product or reduce the dose; initiate symptomatic and supportive care.
Secondary Exposure (Children/Women) Virilization (masculinization) signs, such as premature development of pubic hair, clitoral or phallic enlargement, or aggressive behavior. Seek immediate medical attention.

Procedural Guidance

If overexposure is suspected, immediate action involves discontinuation of the product. The management of overdosage consists of providing appropriate symptomatic and supportive care until the effects subside. Following over-exposure, frequent monitoring of serum testosterone levels and hematocrit may be required to assess the degree of excess and guide further management. Immediate medical attention is required for any signs of virilization in a child or woman resulting from accidental transfer, as this constitutes a serious clinical manifestation of overdosage.

Therapeutic Uses of Tostrex (Testosterone)

Tostrex is a testosterone replacement therapy (TRT) specifically indicated for adult men diagnosed with symptomatic male hypogonadism, which is a condition involving systemic imbalance. This therapy is relevant for easing the challenging cluster of symptoms associated with this deficiency. This replacement therapy may assist with managing these manifestations.

Easing Symptom Burden Across Key Domains

The medication is commonly used to help manage the broad manifestations of deficiency, including symptoms related to sexual vitality (diminished libido, erectile difficulties), neurobehavioral well-being (depressed mood, low motivation), and physical consequences (loss of muscle strength, chronic fatigue). This supports patients in maintaining a sense of stability when these symptoms become more noticeable.

“This therapy is relevant for easing the pervasive clinical consequences of deficiency across multiple domains of health.”


Quick Fact: Support for Chronic Fatigue

Symptom Category Assistance for Comfort
Physical Decline Contributes to easing the burden of chronic fatigue and assists with maintaining functional stability.
Systemic Symptoms Helps address bothersome symptoms such as testosterone-related hot flashes and relevant for easing specific types of anemia.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility for Tostrex (Testosterone) Gel

Tostrex is officially indicated only for adult males diagnosed with symptomatic male hypogonadism (testosterone deficiency). Eligibility for this medicine is strictly defined by government regulatory documents, focusing on both absolute prohibitions and conditional restrictions.


Absolute Prohibitions (Contraindications)

Population/Condition Regulatory Status
Men with known or suspected prostate carcinoma or breast carcinoma CONTRAINDICATED
Women who are pregnant or breastfeeding CONTRAINDICATED
Patients with known hypersensitivity to the active substance or excipients CONTRAINDICATED

Age and Health Restrictions

Use is not indicated for males under 18 years of age as safety and efficacy have not been established. Treatment in men older than 65 has limited experience and requires special monitoring.

Conditional use is required for patients with pre-existing conditions. Tostrex should be used with caution in patients with severe cardiac, renal, or hepatic disease due to the risk of edema. It is not recommended for use in men with uncontrolled hypertension or those with Benign Prostatic Hyperplasia (BPH), who require close monitoring for symptom worsening.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Testosterone (the active ingredient in Tostrex) as established in government regulatory prescribing information. These interactions are primarily classified as pharmacodynamic, meaning they influence physiological effects rather than enzyme metabolism.

Testosterone has been documented to interact with three main classes of co-administered medicines, requiring specific monitoring or caution.


Documented Interaction Patterns

Interacting Medicinal Product Officially Documented Outcome or Constraint
Insulin and Antidiabetic Agents Co-administration may decrease blood glucose levels, which can lead to decreased insulin requirements.
Oral Anticoagulants (e.g., Warfarin) May change anticoagulant activity. Requires more frequent monitoring of the patient’s International Normalized Ratio (INR) and prothrombin time to manage risk.
Corticosteroids and ACTH May result in increased fluid retention (edema) due to additive effects on sodium retention.

Population-Specific Interaction Notes

Increased caution is required for the co-administration of Testosterone with Corticosteroids or ACTH in patients with pre-existing cardiac disease, renal disease, or hepatic disease. This is due to the potential for the increased risk of severe fluid retention being clinically significant in these populations. The official regulatory profile does not list mandatory timing separation requirements or documented interactions with food, alcohol, or herbal products in the primary drug interaction sections.

Mechanism of Action

Tostrex delivers testosterone, which is recognized by target cells as an endogenous hormone. The mechanism involves its passive diffusion across the cell membrane, followed by interaction with intracellular receptors. Within the cell, testosterone may act directly or be converted by the enzyme 5alpha-reductase to its active metabolite, dihydrotestosterone (DHT), or by aromatase to estradiol. Both testosterone and DHT bind to the androgen receptor (AR), a nuclear receptor. This binding triggers the formation of a receptor-ligand complex. The complex then translocates to the nucleus to bind specific DNA sequences known as androgen response elements (AREs). This action modulates the transcription of target genes, thereby altering the synthesis rate of corresponding proteins. These resulting changes in gene expression drive subsequent intracellular signaling cascades that influence cell differentiation, growth, and metabolic processes across androgen-responsive tissues.

Dosage and Administration Information

Administration Scope

Entity Detail
Route of administration Topical (cutaneous) administration to the skin.
Dosing schedule The standard starting dose is 60 mg of testosterone daily (six pump actuations). The dose is then adjusted, not to exceed the maximum daily dose of 80 mg.
Timing in relation to meals (if applicable) The transdermal gel is applied once daily, preferably in the morning.
Preparation requirements (if applicable) Before initial use, the metered-dose pump must be primed by discarding the first six full actuations.
Age-group administration rules The therapy is approved for use in adult men and may be administered to elderly men.
Missed-dose rules If an application is missed, it should be applied as soon as the lapse is noticed. If it is nearly time for the next scheduled dose, the missed dose must be skipped; a double dose should not be applied.
Special procedural conditions The gel must be applied to clean, dry, intact skin of the abdomen or both inner thighs. The application site must be covered with clothing after the gel has dried.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Topical (Transdermal Gel).
Frequency pattern Daily (Once daily).
Regulatory basis Governed by official prescribing information.
Use-context constraints Administration requires dosing titration based on pre-dose morning testosterone blood levels, typically assessed after steady state is reached.

Resulting Procedural Structure

Official step sequence:

  • Priming: Before the first dose, the pump must be primed by discarding six initial actuations.
  • Application: The prescribed number of pump actuations (4 to 8) is applied once daily to clean, dry, intact skin of the abdomen or inner thighs.
  • Washing: Wash hands thoroughly with soap and water immediately after application.
  • Covering: Allow the gel to dry, then cover the application site with clothing.
  • Washing Avoidance: Patients must wait a minimum period (e.g., at least one hour) after application before showering or bathing.
  • Dose Adjustment Protocol: The dose is subsequently adjusted by the prescriber based on the measurement of pre-dose morning serum testosterone concentrations.

Connection to the overall use protocol (2–4 sentences):

These labeled instructions define the standardized procedure for delivering testosterone by specifying the mandatory topical route and the precise once-daily schedule. The protocol mandates a lab-guided dose titration process, which structures the treatment as a monitored, individualized adjustment. Adherence to the stated application site and post-application hygiene is critical to the official administration procedure.

Recent Clinical Evidence

Overview of Clinical Evidence

Tostrex (testosterone) transdermal gel is indicated for testosterone replacement therapy in adult men diagnosed with male hypogonadism. This condition involves clinical symptoms (such as low libido, fatigue, or mood changes) confirmed by persistently low serum testosterone levels.

Efficacy in Symptom Management

Clinical trials, including randomized controlled trials (RCTs), have evaluated the effects of testosterone replacement therapy (TRT) on various symptoms associated with hypogonadism. Studies consistently show that achieving testosterone levels within the normal physiological range is associated with improvements in sexual function and libido. Research has also explored TRT's role in improving mood, vitality, and overall quality of life in symptomatic men, although findings regarding these psychological outcomes can vary across studies.

Metabolic and Physical Effects

Evidence suggests that TRT may affect body composition. Studies have explored whether testosterone therapy, when compared to placebo, is associated with an increase in lean body mass and a reduction in fat mass. Furthermore, research has been conducted to examine the impact of TRT on bone mineral density, with some evidence indicating favorable changes in hypogonadal men.

Safety Profile and Cardiovascular Risk

The safety of TRT, particularly concerning long-term cardiovascular outcomes, has been a key area of recent investigation. The large-scale TRAVERSE trial, a randomized, placebo-controlled study in middle-aged and older men at high risk for cardiovascular events, found that TRT did not increase the incidence of major adverse cardiac events (MACE) over a period of approximately two years. However, this study did observe a higher incidence of certain secondary events in the testosterone group, such as atrial fibrillation and venous thromboembolism (blood clots in veins). The clinical profile requires ongoing monitoring of hematocrit, prostate-specific antigen (PSA) levels, and potential worsening of existing conditions like sleep apnea or severe heart failure.

Frequently Asked Questions (FAQ)

Common questions about Tostrex (Testosterone) (FAQ)

Q: What is the main difference between Tostrex gel and testosterone injections?

According to official product information, testosterone gels like Tostrex are applied daily. This approach is designed to provide a steady, continuous release of the hormone into the bloodstream. In contrast, injections are typically administered less frequently, but they can result in higher peak concentrations immediately following the dose.

Q: How does the gel formulation of Tostrex compare to other topical testosterone gels?

The official product information specifies Tostrex's concentration and directs its application to the abdomen or inner thighs. This is the primary distinction cited in its labeling compared to other available products, which may be directed for use on different areas of the body, such as the shoulders or upper arms.

Q: How long does it typically take for Tostrex to be absorbed into the skin?

Official product information advises allowing the gel to dry for a minimum time before covering the application site with clothing to minimize the risk of transfer. However, full absorption of the testosterone into the body takes longer than the drying period. Regulatory advice requires a minimum waiting period before the application site can be washed or bathed.

Q: Are there specific locations on the body where Tostrex should never be applied?

Official guidelines specify that the gel should not be applied to the genitals or to damaged skin. This is cited to prevent excessive irritation or unintended overabsorption of the medication. The gel should only be applied to clean, dry, and intact skin of the abdomen or inner thighs.

Q: Is it necessary to rotate the application site of the gel daily?

The regulatory method of administration often includes a recommendation to rotate the application site daily. This practice, alternating between the inner thighs or different areas of the abdomen, is intended to help reduce the occurrence of application site reactions like redness or irritation.

Q: What are the risks of accidental secondary exposure to Tostrex for children?

Official warnings clearly state that accidental exposure of Tostrex to children can result in signs of premature puberty. Documented risks include the premature development of pubic hair, aggressive behavior, and in rare cases, genital enlargement. These effects can be serious, which is why prevention of accidental exposure is a primary warning in the regulatory information.

Q: What symptoms should be monitored in a woman or child who may have accidentally contacted the gel?

Official product information lists symptoms of androgen exposure that should be reported to a healthcare provider if accidental contact is suspected. For women, these symptoms include facial or body hair growth, a deepening voice, or menstrual irregularities. In children, one may observe premature pubic hair growth, enlarged genitals, or increased aggression.

Q: Can Tostrex transfer from the skin to bedding or towels?

The official instructions focus on preventing person-to-person contact by covering the application site with clothing once the gel is dry. Covering the site with clothing, as instructed, is intended to prevent transfer and close contact with other people or surfaces. Thorough hand washing immediately after application is also required.

Q: What is the risk level of transfer once the gel has completely dried?

The highest risk of transfer exists before the gel has fully dried and the application site is covered with clothing. Official warnings advise taking measures to reduce transfer risk, which may include covering the site, washing the area before contact, or observing a minimum time interval, such as four hours, before close physical contact.

Q: Can the use of Tostrex lead to changes in hair growth patterns, like body hair or head hair loss?

Changes in hair patterns, such as increased body hair growth or male-pattern hair loss, may occur due to the androgenic effects of testosterone. This finding is a signal that may prompt a healthcare provider to re-evaluate the dosage or continue monitoring for signs of excessive androgen exposure.

Q: Can Tostrex use affect a man's natural sperm production?

The regulatory information confirms that external testosterone can suppress the body's natural hormone production, including the hormones that stimulate sperm production. This can lead to the suppression of spermatogenesis. Due to this known mechanism of action, the product is not indicated as a treatment for male sterility.

Q: How long does it typically take for a person to notice improvements in energy levels after starting Tostrex?

Official information suggests that improvements in overall well-being and related factors like mood and energy are typically noticeable after three to six weeks of continuous treatment. However, the full potential benefit of the treatment may take several months to develop fully.

Q: Is it common to experience fatigue or feel 'off' during the initial weeks of treatment?

The official safety profile notes that certain adverse reactions, such as application site reactions and fluid retention, may be more pronounced at the start of treatment. Any feeling of being unwell or fatigued during the initial weeks should be reported to a healthcare provider as part of the ongoing treatment review.

Q: Can Tostrex influence the results of liver function tests?

For patients receiving long-term androgen therapy, regulatory guidance requires the regular monitoring of several laboratory parameters. These checks include liver function tests, which are officially required to monitor for any changes during the course of treatment.

Q: What happens to the body's own testosterone production when an external gel is used?

The regulatory information confirms that external testosterone reduces the pituitary secretion of the hormones that stimulate natural testosterone production. This process, sometimes called negative feedback, leads to the suppression of the body’s own natural testosterone production.

Q: Does Tostrex have any known effects on cholesterol levels?

Official warnings indicate that for patients undergoing long-term androgen therapy, regular monitoring of the body's lipid profile is required. This monitoring includes checking cholesterol levels, which is one of several required lab parameters evaluated during follow-up visits.

Q: How is Tostrex different from other testosterone brands that use different application sites?

Tostrex is officially distinguished by its recommendation for application strictly to the abdomen or inner thighs, as stated in its prescribing information. This differs from other brands where different application sites are specified in their regulatory profiles.

Q: Can exercise habits influence the way Tostrex is absorbed or works?

The application instructions, which require the gel to be applied to clean, dry skin and mandate avoiding washing for a minimum time, suggest that activities causing excessive sweating or requiring immediate washing should be postponed. This helps ensure proper absorption.

How should Tostrex (Testosterone) be stored and disposed of?

Storage and Disposal Requirements for Tostrex (Testosterone)

The official storage conditions for Tostrex transdermal gel require that the product be kept at a temperature not above 25°C. The medicine must not be refrigerated or frozen. The multi-dose canister should be stored in the upright position when not in use.

Stability and Child Safety

Once the Tostrex canister is first opened, the gel remains stable for 60 days under the specified storage conditions. The product is also classified as flammable until dry due to its formulation and must be kept away from open flames. All medicine must be stored out of the sight and reach of children.

Official Disposal

Specific instructions mandate that the initial priming doses of the gel must be safely discarded into household waste, away from children or pets. Unused or expired gel should not be disposed of via wastewater. Instead, it should be mixed with an unappealing substance, placed in a sealed container, and then discarded in the household trash, or returned to a drug take-back location.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tostrex (Testosterone) found in:

A-Z Index: